Absolutely DeltaVee. This point has been mentioned before but it seems some still don't understand the magnitude of the difference between this Phase 1b and those conducted for acne and AD.
For those still in doubt ring Matt and speak to him about it (though he probably can't say much right now I suppose!). Those who did speak to him about this will (or at least should!) understand..
These are hugely significant results.
The initial delays in tailoring the output designs for this Phase 1b also lead me to believe we have set this up to provide third parties (JV partners, 'big' pharma, etc ?) with the information they need to take action with regards to BOT.
Perhaps that action ties in with Vince/Change of Management incentives/partnerships/takeovers..
Ann: Trading Halt, page-37
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |